Tabula Rasa HealthCare Receivables

The latest receivables for TRHC is $39M as of June 2023. That compares with $58M in the prior-year period — down 33.0% year over year. Investors often review this figure alongside Tabula Rasa HealthCare's historical trend and sector peers before judging valuation or financial health.

Over the past year, TRHC's receivables moved from $58M to $39M — a 33.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tabula Rasa HealthCare's operating scale or balance-sheet position.

A receivables figure of $39M for TRHC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TRHC's receivables ($39M), review year-over-year change from $58M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Tabula Rasa HealthCare's receivables against similar Consumer Staples names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Staples companies and their key multiples and fundamentals.